Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
Recursion refreshes leadership with CEO swap—Chutes & Ladders
Recursion refreshes leadership team with CEO swap. Ratio nabs Novartis vet as strategy chief. Draig looks to soar with new neuro CEO.
Darren Incorvaia
,
Zoey Becker
Nov 7, 2025 8:30am
FDA reveals 2nd round of 'national priority' voucher winners
Nov 6, 2025 3:12pm
Lilly links amylin drug to 20% weight loss, races to phase 3
Nov 6, 2025 8:20am
Lilly pulls out of CNS portion of $960M collab with Rigel
Nov 5, 2025 7:00am
Lilly inks $345M antibody pact with XtalPi subsidiary
Nov 5, 2025 7:00am
Eli Lilly sidelines pain prospect in another pipeline shift
Oct 30, 2025 2:19pm